The Intergroup Rhabdomyosarcoma Study-I. A final report.
about
Postauricular congenital alveolar rhabdomyosarcoma- a case report of an unusual entityTreatment including anthracyclines versus treatment not including anthracyclines for childhood cancerTreatment including anthracyclines versus treatment not including anthracyclines for childhood cancerTreatment including anthracyclines versus treatment not including anthracyclines for childhood cancerProgress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology GroupChildren's Oncology Group's 2013 blueprint for research: Soft tissue sarcomasPI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cellsRapid VAC high dose melphalan regimen, a novel chemotherapy approach in childhood soft tissue sarcomasRole of radiation therapy in parameningeal rhabdomyosarcoma.Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studiesPrimary renal sarcomas in the Intergroup Rhabdomyosarcoma Study Group (IRSG) experience, 1972-2005: A report from the Children's Oncology GroupNeoadjuvant hormonal therapy in carcinoma of the prostate.Testicular and paratesticular tumours in children: 30 years' experience.Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and theBenign and malignant neoplasms of the periodontium.Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.Outcome for children with metastatic solid tumors over the last four decadesProgress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.Rhabdomyosarcoma: a rare laryngeal neoplastic entity.Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups.Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Fédération Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems.Primary ophthalmic rhabdomyosarcoma in 33 patients.Population-based survival estimates for childhood cancer in Australia during the period 1997-2006.Clear cell sarcoma of tendons and aponeuroses in pediatric patients: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group.Distinctive soft tissue tumors of the head and neck.Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.Epidemiology and therapies for metastatic sarcomaSynovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group.Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from thDeep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family membersRegional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group.Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology GroupImpact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group.Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group.Treatment modalities of bladder/prostate rhabdomyosarcoma: a review.Sinonasal rhabdomyosarcoma: prognostic factors and treatment outcomes.Avoiding chemotherapy related late effects in children with curable tumours
P2860
Q21203688-C0A91717-792E-41D8-8C9E-C966FBB98EFEQ24193790-D761920A-2E1D-4441-A797-02375CB8533BQ24234833-EF5C9D94-4130-437A-AB53-6A58C29AF43EQ24241602-87607972-1111-4E0C-8EC6-8D409FDB9F32Q24657000-1BFC0594-F004-465F-98B0-B6ED75EC78C7Q26825000-412E004B-FCC9-4B79-8660-2B651B333F86Q28484680-4361611E-2B3C-408B-8561-6BAFCC36A3B0Q30372745-B456C7D0-C414-4765-8821-50F54ACE9913Q33547208-C5E0B32E-91F0-4213-903F-0D8E56DDEB3FQ33559468-98123D0D-63ED-4903-88D9-FF53AE608AFAQ33577061-19D07E0B-C88D-41C7-9554-364992DFC73EQ33598081-176D0DF8-4F32-4654-A31F-D0C3E283527BQ33708818-A806278B-FEA5-4F05-8FF9-BBB316E236BBQ33734718-85A0BC7A-7E93-406D-A547-DACC02522DABQ33768613-AEB8E083-C1B0-47D1-A2D7-C82A4E6D4E51Q33800135-278FBF7B-D3A1-4CE0-8D9C-B893EF0230D6Q33863587-5EF9F7EC-C23A-4404-92F5-9CA76D158761Q33885722-8BBCCC34-5484-4899-9DCF-7CAB92CCBF9EQ33897154-756BAED6-B9F8-4AFE-A2CB-17B3A41E48E9Q34113333-BE7B3A4B-2D64-4386-BD44-9798DA9A8FD2Q34154064-0EDB5433-D335-46C1-8B88-47AA9BC27042Q34330627-81C8BBAC-B723-451D-BA60-95F7AF00D6F9Q34331146-58AD1B2C-294F-463D-9922-62CDB3ECFD1BQ34363570-F56F53D7-1522-48D1-9063-F79237111A72Q34525252-3B778BF9-C3A0-43A7-82DC-0D6A5F34D4B8Q34571138-9A0E5F8E-865D-41B2-BE73-7ABFE89C6B12Q34589401-D8C4516C-4FF3-496F-BC0E-32238AC12613Q34652142-D4DB1389-D9C7-4602-AF23-B268FD530E4DQ34666948-09134F52-646E-4D37-93FB-C720D8D2C1C5Q34688987-D6502E39-736B-4E9A-8C2E-D8D85922216DQ34786004-0FBA4F08-CEE0-4B90-8E08-E417134B006AQ34879307-0898B803-1BD5-466B-A4E2-527C095E5047Q34894993-FAF848F0-27C6-4EF4-B361-398861CD7CEFQ35048131-8C05F7ED-DCD1-4EB0-AA1F-48A0DB7EEC63Q35084182-9B920140-2165-42EA-AC3B-7E8B9A0DB649Q35084188-E0983470-930F-4C8C-8D6E-4BE3FF2E9994Q35119012-923A918A-45D1-4888-A736-D56CE09A781CQ35154422-7EFF766C-0605-432B-8266-D7739BF44A93Q35174473-C94B273C-F672-4CD9-97CD-19EF0B8B2A95Q35448174-944A5977-58BE-4305-A38C-C25443423FCA
P2860
The Intergroup Rhabdomyosarcoma Study-I. A final report.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
name
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@ast
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@en
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@nl
type
label
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@ast
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@en
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@nl
prefLabel
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@ast
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@en
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@nl
P2093
P1433
P1476
The Intergroup Rhabdomyosarcoma Study-I. A final report.
@en
P2093
Beltangady M
Lawrence W
P304
P356
10.1002/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L
P407
P577
1988-01-01T00:00:00Z